These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15953428

  • 1. Cataract progression after intravitreal triamcinolone injection.
    Cekiç O, Chang S, Tseng JJ, Akar Y, Barile GR, Schiff WM.
    Am J Ophthalmol; 2005 Jun; 139(6):993-8. PubMed ID: 15953428
    [Abstract] [Full Text] [Related]

  • 2. Cataract formation and other complications of intravitreal triamcinolone for macular edema.
    Thompson JT.
    Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
    Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W, Simpson JM.
    Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
    [Abstract] [Full Text] [Related]

  • 4. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB, Scott IU, Gloth JM, Green SN, Yarian DL, Wheatley M.
    Retina; 2007 Jan; 27(9):1201-4. PubMed ID: 18046225
    [Abstract] [Full Text] [Related]

  • 5. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
    Chu YK, Chung EJ, Kwon OW, Lee JH, Koh HJ.
    Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS, Vernon SA, Negi A.
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H, Taheri A, Farahvash MS, Esfahani MR, Rajabi MT.
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [Abstract] [Full Text] [Related]

  • 8. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
    Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.
    Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
    [Abstract] [Full Text] [Related]

  • 9. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
    Lee J, Freeman WR, Azen SP, Chung EJ, Koh HJ.
    Retina; 2007 Jun; 27(9):1205-13. PubMed ID: 18046226
    [Abstract] [Full Text] [Related]

  • 10. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA, Melo LA, Costa RA, Skaf M, Belfort R, Souza-Filho AA, Farah ME, Kuppermann BD.
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [Abstract] [Full Text] [Related]

  • 11. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
    Kim SY, Yang J, Lee YC, Park YH.
    J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
    [Abstract] [Full Text] [Related]

  • 12. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
    Wu L, Evans T, Arévalo JF, Berrocal MH, Rodríguez FJ, Hsu M, Sánchez JG.
    Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037
    [Abstract] [Full Text] [Related]

  • 13. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G.
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L, Allingham RR, Singh I, Stinnett S, Fekrat S.
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
    Ozkiris A.
    Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985
    [Abstract] [Full Text] [Related]

  • 17. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB.
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T, Longo A, Reibaldi A.
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [Abstract] [Full Text] [Related]

  • 19. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM, Chiu YT, Hung PT, Tsai YY.
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [Abstract] [Full Text] [Related]

  • 20. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
    Jonas JB, Spandau UH, Kamppeter BA, Harder B.
    Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.